JAMA Oncology/X
Jun 16, 2026, 15:26
JAMA Oncology: Avelumab Plus Methotrexate in Gestational Trophoblastic Tumors
JAMA Oncology shared a post on X about a paper by Benoit You et al. published in JAMA Oncology:
“Avelumab combined with methotrexate resulted in >95% durable remission and preserved fertility in low-risk gestational trophoblastic tumors, with a manageable safety profile.”
Title: Avelumab Plus Methotrexate for Gestational Trophoblastic Tumors
Authors: Benoit You, Jean-Pierre Lotz, Pierre Descargues
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 18, 2026, 02:58Outstanding Challenges in Maternal–Perinatal Health – FIGO
-
Jun 18, 2026, 02:11Understanding the Risks of Unregulated Sperm Donation – HFEA
-
Jun 18, 2026, 02:07Javed Anees: ATA 2026 Guidelines – A New Era in Thyroid Care During Pregnancy
-
Jun 17, 2026, 11:17Asma Khalil: Preconception Health Remains One of the Most Underutilised Opportunities
-
Jun 17, 2026, 11:08Marco Zaccaria: Enhanced Myometrial Vascularity: Ultrasound Findings and Clinical Context
-
Jun 17, 2026, 11:01Femi Oladapo: Global Pre-eclampsia Summit: Aligning Priorities for Impact
-
Jun 17, 2026, 10:51Christopher Robinson: Isolated Fetal Ventricular Septal Defect and Chromosomal-Genomic Abnormalities!
-
Jun 17, 2026, 10:47New Evidence on Recurrent Implantation Failure – ESHRE
-
Jun 17, 2026, 10:44Timed Intercourse and Fertile Window Monitoring: What the Data Shows – Fertility Plus